Titanium dioxide (TiO2) nanoparticles have been explored to prevent various
cancer developments but it may cause oxidation,
inflammation and high cytotoxicity.
Alginate has nontoxic, anti-inflammatory, and
antioxidant effects. We aimed to explore the effects of alginate-TiO2
temozolomide (TMZ) nanoparticles on
neuroblastoma. A
neuroblastoma model was established with
neuroblastoma cells and alginate-TiO2 TMZ nanoparticles were made by spraying low-viscosity
sodium alginate (250-360 kDa). The morphology of nanoparticles was observed via scanning electron microscope (SEM). The crystallinity values were analyzed via X-ray diffraction (XRD) and Fourier transform infrared (FTIR) spectroscopic study.
Neuroblastoma mice were treated with
saline solution, TMZ, TiO2-TMZ and alginate-TiO2-TMZ nanoparticles.
Anti-oxidant, anti-inflammatory, and anti-
tumor properties and the mouse survival rates were measured. The spectrometric profiles of alginate-TiO2 were consistent with those of TiO2 and
alginate. Alginate-TiO2 TMZ nanoparticles had higher cytotoxicity toward
neuroblastoma cells and less inhibitory activity toward normal neuronal cells. The combined nanoparticles increased
antioxidant, anti-inflammatory and antitumor activities and prolonged the survival time of the
neuroblastoma model (P < 0.05). On the other hand, Alginate-TiO2 TMZ nanoparticles reduced the levels of
mitogen-activated protein kinases (MAPKs) and nuclear factor-κB (NF-κB). The combined nanoparticles improved
neuroblastoma treatment by affecting NF-κB and MAPK signals.